Jan Kłos

551 total citations
19 papers, 441 citations indexed

About

Jan Kłos is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jan Kłos has authored 19 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Jan Kłos's work include HER2/EGFR in Cancer Research (5 papers), Reproductive Biology and Fertility (4 papers) and Reproductive Physiology in Livestock (4 papers). Jan Kłos is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Reproductive Biology and Fertility (4 papers) and Reproductive Physiology in Livestock (4 papers). Jan Kłos collaborates with scholars based in Norway, Netherlands and Poland. Jan Kłos's co-authors include Ivar Skaland, Jan P. A. Baak, Kjell H. Kjellevold, Einar Gudlaugsson, Emiel A. M. Janssen, Håvard Søiland, Emiel A. M. Janssen, Jan P. A. Baak, Irene Tveiterås Øvestad and Tone Hoel Lende and has published in prestigious journals such as Scientific Reports, The Lancet Infectious Diseases and Biology of Reproduction.

In The Last Decade

Jan Kłos

17 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Kłos Norway 12 168 145 121 75 66 19 441
Emily Reisenbichler United States 13 236 1.4× 187 1.3× 111 0.9× 85 1.1× 108 1.6× 39 538
H. Dawkins Australia 6 139 0.8× 200 1.4× 159 1.3× 101 1.3× 42 0.6× 9 461
M. M. M. Pahlplatz Netherlands 12 80 0.5× 96 0.7× 158 1.3× 32 0.4× 45 0.7× 28 447
Stephanie G. Craig United Kingdom 17 314 1.9× 130 0.9× 257 2.1× 87 1.2× 92 1.4× 49 796
Miluska Castillo Peru 11 377 2.2× 142 1.0× 84 0.7× 37 0.5× 63 1.0× 42 645
Teresa Lettini Italy 11 130 0.8× 32 0.2× 61 0.5× 40 0.5× 36 0.5× 62 364
Sebastiana Boi Italy 17 406 2.4× 66 0.5× 84 0.7× 133 1.8× 34 0.5× 33 728
Takayuki Kobayashi Japan 15 200 1.2× 135 0.9× 194 1.6× 57 0.8× 98 1.5× 65 616
Pablo Zoroquiaín Canada 11 112 0.7× 39 0.3× 95 0.8× 28 0.4× 85 1.3× 64 381
Guinebretière Jm France 11 217 1.3× 209 1.4× 109 0.9× 128 1.7× 35 0.5× 22 474

Countries citing papers authored by Jan Kłos

Since Specialization
Citations

This map shows the geographic impact of Jan Kłos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Kłos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Kłos more than expected).

Fields of papers citing papers by Jan Kłos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Kłos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Kłos. The network helps show where Jan Kłos may publish in the future.

Co-authorship network of co-authors of Jan Kłos

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Kłos. A scholar is included among the top collaborators of Jan Kłos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Kłos. Jan Kłos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ziȩcik, Adam J., Jan Kłos, Katarzyna Knapczyk‐Stwora, et al.. (2023). Atretic preovulatory follicles could be precursors of ovarian lutein cysts in the pig. Scientific Reports. 13(1). 7758–7758.
2.
Przygrodzka, Emilia, Kamil Myszczyński, Jan Kłos, & Adam J. Ziȩcik. (2022). The Role of Reduced Oxygen Supply and Transcription Factors cJUN and CREB in Progesterone Production during the Corpus Luteum Rescue in Gilts. Animals. 12(20). 2855–2855.
3.
Ziȩcik, Adam J., et al.. (2020). Altrenogest affects the development and endocrine milieu of ovarian follicles in prepubertal and mature gilts†. Biology of Reproduction. 103(5). 1069–1084. 12 indexed citations
4.
Vikse, Jens, Jan Kłos, & Åse Berg. (2017). A travelling camper with a spiking fever, headache, myalgia, hepatitis, and intracellular inclusions. The Lancet Infectious Diseases. 17(12). 1318–1318. 3 indexed citations
5.
Ziȩcik, Adam J., Jan Kłos, Emilia Przygrodzka, Robert Milewski, & Barbara Jana. (2016). Aberrant effects of altrenogest and exposure to exogenous gonadotropins on follicular cysts appearance in gilts. Theriogenology. 89. 250–254. 16 indexed citations
6.
Kłos, Jan, et al.. (2016). Extranodal NK/T-cell lymphoma, nasal type, primarily involving ovary. Human Pathology Case Reports. 9. 58–60. 1 indexed citations
7.
Janssen, Emiel A. M., et al.. (2015). Reduced Number of CD8+ Cells in Tonsillar Germinal Centres in Children with the Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome. Scandinavian Journal of Immunology. 82(1). 76–83. 17 indexed citations
9.
Helgeland, Lars, et al.. (2009). Improved Diagnostic Segregation of Mantle Cell Lymphoma by Determination of Cyclin D1/D3 Expression Ratio in Formalin-fixed Tissue. Diagnostic Molecular Pathology. 18(3). 150–155. 3 indexed citations
10.
Skaland, Ivar, Einar Gudlaugsson, Jan Kłos, et al.. (2009). Evaluation of 5 Different Labeled Polymer Immunohistochemical Detection Systems. Applied immunohistochemistry & molecular morphology. 18(1). 90–96. 24 indexed citations
11.
Skaland, Ivar, Irene Tveiterås Øvestad, Emiel A. M. Janssen, et al.. (2008). Digital Image Analysis Improves the Quality of Subjective HER-2 Expression Scoring in Breast Cancer. Applied immunohistochemistry & molecular morphology. 16(2). 185–190. 25 indexed citations
12.
Baak, Jan P. A., Einar Gudlaugsson, Ivar Skaland, et al.. (2008). Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers. Breast Cancer Research and Treatment. 115(2). 241–254. 61 indexed citations
13.
Skaland, Ivar, Emiel A. M. Janssen, Einar Gudlaugsson, et al.. (2008). Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age. Breast Cancer Research and Treatment. 114(1). 39–45. 43 indexed citations
14.
Skaland, Ivar, Irene Tveiterås Øvestad, Emiel A. M. Janssen, et al.. (2007). Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer. Journal of Clinical Pathology. 61(1). 68–71. 55 indexed citations
15.
Skaland, Ivar, Emiel A. M. Janssen, Einar Gudlaugsson, et al.. (2007). Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age. Modern Pathology. 20(12). 1307–1315. 91 indexed citations
16.
Kruse, Arnold‐Jan, Ivar Skaland, Emiel A. M. Janssen, et al.. (2004). Quantitative Molecular Parameters to Identify Low-Risk and High-Risk Early CIN Lesions: Role of Markers of Proliferative Activity and Differentiation and Rb Availability. International Journal of Gynecological Pathology. 23(2). 100–109. 42 indexed citations
17.
Kłos, Jan, et al.. (1990). Efficacy and tolerance of nifedipine retard vs acebutolol in patients with essential hypertension treated for 26 weeks.. PubMed. 21(1). 49–52. 2 indexed citations
18.
Kłos, Jan. (1970). Clinical Course of Laryngeal Papillomatosis in Children. Annals of Otology Rhinology & Laryngology. 79(6). 1132–1138. 13 indexed citations
19.
Kłos, Jan, et al.. (1966). XX A Cytopathic Agent in Laryngeal Papillomas of Children. Annals of Otology Rhinology & Laryngology. 75(1). 225–234. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026